Efficacy and safety of antibody-drug conjugates in pretreated HER2-low metastatic breast cancer: A systematic review and network meta-analysis

Francesco Schettini 1; Sabrina Nucera 2; Tomás Pascual 3; Olga Martínez-Sáez 3; Rodrigo Sánchez-Bayona 4; Benedetta Conte 5; Giuseppe Buono 6; Matteo Lambertini 7; Kevin Punie 8; Juan Miguel Cejalvo 9; Grazia Arpino 10; Paolo Vigneri 11; Daniele Generali 12; Eva Ciruelos 4; Javier Cortés 13; Alessandra Gennari; Montserrat Muñoz 15; Maria J Vidal Losada 15; Sara M Tolaney 16; Aleix Prat 17; Guillermo Villacampa

doi:10.1016/j.ctrv.2024.102865

Efficacy and safety of antibody-drug conjugates in pretreated HER2-low metastatic breast cancer: A systematic review and network meta-analysis

Francesco Schettini 1, Sabrina Nucera 2, Tomás Pascual 3, Olga Martínez-Sáez 3, Rodrigo Sánchez-Bayona 4, Benedetta Conte 5, Giuseppe Buono 6, Matteo Lambertini 7, Kevin Punie 8, Juan Miguel Cejalvo 9, Grazia Arpino 10, Paolo Vigneri 11, Daniele Generali 12, Eva Ciruelos 4, Javier Cortés 13, Alessandra Gennari, Montserrat Muñoz 15, Maria J Vidal Losada 15, Sara M Tolaney 16, Aleix Prat 17Guillermo Villacampa

Dipartimento di Medicina Traslazionale

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Lingua originale	Inglese
Rivista	Cancer Treatment Reviews
Volume	132
DOI	https://doi.org/10.1016/j.ctrv.2024.102865
Stato di pubblicazione	Pubblicato - 2025

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1016/j.ctrv.2024.102865

https://hdl.handle.net/11579/203142

Altri file e collegamenti

handle

Cita questo

1, F. S., 2, S. N., 3, T. P., 3, O. M.-S., 4, R. S.-B., 5, B. C., 6, G. B., 7, M. L., 8, K. P., 9, J. M. C., 10, G. A., 11, P. V., 12, D. G., 4, E. C., 13, J. C., Gennari, A., 15, M. M., 15, M. J. V. L., 16, S. M. T., ... Villacampa, G. (2025). Efficacy and safety of antibody-drug conjugates in pretreated HER2-low metastatic breast cancer: A systematic review and network meta-analysis. Cancer Treatment Reviews, 132. https://doi.org/10.1016/j.ctrv.2024.102865

@article{cb6aeddf35be4ecdbe569b7263b09153,

title = "Efficacy and safety of antibody-drug conjugates in pretreated HER2-low metastatic breast cancer: A systematic review and network meta-analysis",

author = "1, {Francesco Schettini} and 2, {Sabrina Nucera} and 3, {Tom{\'a}s Pascual} and 3, {Olga Mart{\'i}nez-S{\'a}ez} and 4, {Rodrigo S{\'a}nchez-Bayona} and 5, {Benedetta Conte} and 6, {Giuseppe Buono} and 7, {Matteo Lambertini} and 8, {Kevin Punie} and 9, {Juan Miguel Cejalvo} and 10, {Grazia Arpino} and 11, {Paolo Vigneri} and 12, {Daniele Generali} and 4, {Eva Ciruelos} and 13, {Javier Cort{\'e}s} and Alessandra Gennari and 15, {Montserrat Mu{\~n}oz} and 15, {Maria J Vidal Losada} and 16, {Sara M Tolaney} and 17, {Aleix Prat} and Guillermo Villacampa",

year = "2025",

doi = "10.1016/j.ctrv.2024.102865",

language = "English",

volume = "132",

journal = "Cancer Treatment Reviews",

issn = "0305-7372",

publisher = "W.B. Saunders Ltd",

}

1, FS, 2, SN, 3, TP, 3, OM-S, 4, RS-B, 5, BC, 6, GB, 7, ML, 8, KP, 9, JMC, 10, GA, 11, PV, 12, DG, 4, EC, 13, JC, Gennari, A, 15, MM, 15, MJVL, 16, SMT, 17, AP & Villacampa, G 2025, 'Efficacy and safety of antibody-drug conjugates in pretreated HER2-low metastatic breast cancer: A systematic review and network meta-analysis', Cancer Treatment Reviews, vol. 132. https://doi.org/10.1016/j.ctrv.2024.102865

TY - JOUR

T1 - Efficacy and safety of antibody-drug conjugates in pretreated HER2-low metastatic breast cancer: A systematic review and network meta-analysis

AU - 1, Francesco Schettini

AU - 2, Sabrina Nucera

AU - 3, Tomás Pascual

AU - 3, Olga Martínez-Sáez

AU - 4, Rodrigo Sánchez-Bayona

AU - 5, Benedetta Conte

AU - 6, Giuseppe Buono

AU - 7, Matteo Lambertini

AU - 8, Kevin Punie

AU - 9, Juan Miguel Cejalvo

AU - 10, Grazia Arpino

AU - 11, Paolo Vigneri

AU - 12, Daniele Generali

AU - 4, Eva Ciruelos

AU - 13, Javier Cortés

AU - Gennari, Alessandra

AU - 15, Montserrat Muñoz

AU - 15, Maria J Vidal Losada

AU - 16, Sara M Tolaney

AU - 17, Aleix Prat

AU - Villacampa, Guillermo

PY - 2025

Y1 - 2025

UR - https://iris.uniupo.it/handle/11579/203142

U2 - 10.1016/j.ctrv.2024.102865

DO - 10.1016/j.ctrv.2024.102865

M3 - Article

SN - 0305-7372

VL - 132

JO - Cancer Treatment Reviews

JF - Cancer Treatment Reviews

ER -